Clinical trial
A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis
NCT01180491 is registered in ClinicalTrials.gov with Moberg Pharma AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis
- Lead sponsor
- Moberg Pharma AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- November 30, 2010
- Enrollment
- 75 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.